IL-12 GEMys
Refractory Solid Tumor Malignancies
National Cancer Institute (NCI)Phase 1
—
Rating in progress
IL-12 GEMys in Refractory Solid Tumor Malignancies is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active